FDA Inspection 1262952 — Huilai Tianjin Zhang
The FDA completed an inspection of Huilai Tianjin Zhang on Feb 21, 2025 in Tianjin. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Feb 21, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Tianjin (China)
Additional Details
Clinical Investigator (CI)